Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T

NMR in Biomedicine

Volumn 24, Issue 3, 2011, Pages 325-334

  Song, Ho Taek ^a,b   Jordan, Elaine K ^a   Lewis, Bobbi K ^a   Gold, Eric ^a   Liu, Wei ^a,c   Frank, Joseph A ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Brain metastasis; Breast cancer; Cellular tracking; Dormant breast cancer cell; Histogram; MRI; Quantification; Superparamagnetic iron oxide (SPIO); T2* map

Indexed keywords

BRAIN METASTASIS; BREAST CANCER; CELLULAR TRACKING; DORMANT BREAST CANCER CELL; HISTOGRAM; MRI; QUANTIFICATION; SUPERPARAMAGNETIC IRON OXIDES;

ANIMALS; CELL DEATH; GRAPHIC METHODS; IRON OXIDES; MACROPHAGES; METAL ANALYSIS; PATHOLOGY; RATS; SUPERPARAMAGNETISM;

DISEASES;

FERRIC FERROCYANIDE; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; DEXTRAN; MAGNETITE NANOPARTICLE; PROTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CELL LABELING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RELAXATION TIME; VOXEL BASED MORPHOMETRY; ANIMAL; BRAIN TUMOR; BREAST TUMOR; CANCER TRANSPLANTATION; METABOLISM; METASTASIS; METHODOLOGY; NUDE RAT; PATHOLOGY; TUMOR CELL LINE;

ANIMALIA; RATTUS; SOLENOIDEA;

ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DEXTRANS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTAMINES; RATS; RATS, NUDE;

EID: 79952648874     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1596     Document Type: Article

References (54)

1. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation, 2003; 76: 1123-1130.
2. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology, 2003; 229: 838-846.
3. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood, 2004; 104: 1217-1223.
4. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19: 1141-1147.
5. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology, 2003; 228: 760-767.
6. Frank JA, Anderson SA, Kalsih H, Jordan EK, Lewis BK, Yocum GT, Arbab AS. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy, 2004; 6: 621-625.
7. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology, 2003; 228: 480-487.
8. Frank JA, Zywicke H, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH Jr, Bulte JW. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 2002; 9: S484-S4.
9. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA, 2002; 99: 16, 267-16, 272.
10. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med. 2006; 355: 2376-2378.
11. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood, 2005; 105: 420-425.
12. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 2004; 55: 654-659.
13. Arbab AS, Liu W, Frank JA. Cellular magnetic resonance imaging: current status and future prospects. Exp. Rev. Med. Devices, 2006; 3: 427-439.
14. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005; 23: 1407-1413.
15. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.
16. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS, Yoneda T, MacDonald IC, Chambers AF, Rutt BK, Foster PJ. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn. Reson. Med. 2006; 56: 1001-1010.
17. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, Frenkel V, Khuu HM, Read EJ, Frank JA. Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells (Dayton, Ohio), 2006; 24: 671-678.
18. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol. Imaging, 2005; 4: 143-164.
19. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA, 1999; 96; 15, 256-15, 261.
20. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled cells with FIESTA. Magn. Reson. Med. 2005; 53: 312-320.
21. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 2005; 53: 329-338.
22. Liu W, Dahnke H, Jordan EK, Schaeffter T, Frank JA. In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed. 2008; 21: 242-250.
23. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 2007; 58: 261-269.
24. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed. 2006; 19: 581-592.
25. Rad AM, Arbab AS, Iskander AS, Jiang Q, Soltanian-Zadeh H. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI. J. Magn. Reson. Imaging, 2007; 26: 366-374.
26. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn. Reson. Med. 2003; 49: 968-971.
27. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AF, Rutt BK, Foster PJ. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med. 2006; 55: 23-29.
28. Sumner JP, Shapiro EM, Maric D, Conroy R, Koretsky AP. In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: quantification of labeled cell phenotype. Neuroimage, 2009; 44: 671-678.
29. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn. Reson. Med. 2006; 55: 242-249.
30. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. USA, 2004; 101: 10, 901-10, 906.
31. Ye Q, Wu YL, Foley LM, Hitchens TK, Eytan DF, Shirwan H, Ho C. Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation, 2008; 118: 149-156.
32. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J. 1999; 76: 103-109.
33. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000; 18: 410-414.
34. Dahnke H, Schaeffter T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn. Reson. Med. 2005; 53: 1202-1206.
35. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P, Scharenborg NM, Bulte JW, Punt CJ, Heerschap A, Figdor CG, de Vries IJ. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int. J. Cancer, 2007; 120: 978-984.
36. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003; 63: 6838-6846.
37. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res. 2001; 16: 1486-1495.
38. Song HT, Jordan EK, Lewis BK, Liu W, Ganjei J, Klaunberg B, Despres D, Palmieri D, Frank JA. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J. Transl. Med. 2009; 7: 88.
39. Tukey JW. Some selected quick and easy methods of statistical analysis. Trans. NY Acad. Sci. 1953; 16: 88-97.
40. Majumdar S, Zoghbi SS, Gore JC. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Invest. Radiol. 1990; 25: 771-777.
41. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn. Reson. Med. 2006; 55: 126-135.
42. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn. Reson. Med. 2003; 50: 784-790.
43. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur. J. Radiol. 2009; 70: 258-264.
44. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, Vonken EJ, Bulte JW, Kraitchman DL. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn. Reson. Med. 2007; 58: 1072-1077.
45. Zurkiya O, Hu X. Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles. Magn. Reson. Med. 2006; 56: 726-732.
46. Farrar CT, Dai G, Novikov M, Rosenzweig A, Weissleder R, Rosen BR, Sosnovik DE. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed. 2008; 21: 453-463.
47. Mowat P, Franconi F, Chapon C, Lemaire L, Dorat J, Hindre F, Benoit JP, Richomme P, Le Jeune JJ. Evaluating SPIO-labelled cell MR efficiency by three-dimensional quantitative T2* MRI. NMR Biomed. 2007; 20: 21-27.
48. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BM, Wahl RL, Bulte JW. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation, 2005; 112: 1451-1461.
49. Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Mult. Scler. 2007; 13: 708-716.
50. Ostuni JL, Richert ND, Lewis BK, Frank JA. Characterization of differences between multiple sclerosis and normal brain: a global magnetization transfer application. Am. J. Neuroradiol. 1999; 20: 501-507.
51. Pagani E, Bammer R, Horsfield MA, Rovaris M, Gass A, Ciccarelli O, Filippi M. Diffusion MR imaging in multiple sclerosis: technical aspects and challenges. Am. J. Neuroradiol. 2007; 28: 411-420.
52. Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA, Neeman M. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res. 2007; 67: 9180-9189.
53. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003; 63: 8122-8125.
54. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 2010; 16: 116-122.